Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up

Publication date

2022-12

Authors

ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc_nd

Abstract

This ESMO–EURACAN Clinical Practice Guideline provides key recommendations for managing salivary gland cancer. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. • Treatment algorithms for parotid, submandibular, sublingual and minor salivary gland cancer are provided. • The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe. • Recommendations are based on available scientific data and the authors’ collective expert opinion.

Keywords

ESMO–EURACAN Clinical Practice Guideline, diagnosis, follow-up, salivary gland cancer, treatment, Oncology, Cancer Research, Practice Guideline

Citation

ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org 2022, 'Salivary gland cancer : ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up', ESMO open, vol. 7, no. 6, 100602, pp. 1-16. https://doi.org/10.1016/j.esmoop.2022.100602